The Institute will have research laboratories within the new Capella Building on the Cambridge Biomedical Campus. The laboratories are expected to be operational in late 2018 and will accommodate scientists from affiliated research groups from the Cambridge academic centres and from our affiliated pharmaceutical partners. The Milner Research Labs are envisaged to house an Innovation Unit with bioinformatics, disease models, and robotics for customised phenotypic drug screening. It is also expected to house an Accelerator Unit, which will welcome entrepreneurs to develop ideas for therapeutic companies.

Pin It on Pinterest